Management of Elevated Lipase and Amylase

Initial Diagnostic Confirmation

Elevations ≥3 times the upper limit of normal (≥3× ULN) are most consistent with acute pancreatitis, though levels <3× ULN do not exclude severe disease 1
Lipase is superior to amylase for diagnosis with 79% vs 72% sensitivity and remains elevated longer (8-14 days vs 3-7 days) 1, 2
The severity of pancreatitis is completely independent of the degree of enzyme elevation—patients with minimal elevations can develop severe disease and organ failure 1
Diagnosis requires upper abdominal pain with epigastric or diffuse tenderness, plus enzyme elevation 1
Consider pancreatitis in any patient with unexplained multiorgan failure or systemic inflammatory response syndrome 1

Perform ultrasound in all suspected cases to detect gallstones, biliary dilation, or free peritoneal fluid 1
If gallstones are identified with severe pancreatitis, urgent ERCP should be considered 1
Order CT only if clinical/biochemical findings are inconclusive, APACHE II score >8, or organ failure develops 1
Do not perform CT within the first 72 hours of symptom onset, as early imaging underestimates pancreatic necrosis 1, 3

Use APACHE II scoring with cutoff of 8 as the preferred severity assessment tool 1
Alternative markers include C-reactive protein >150 mg/L or Glasgow score ≥3 1
Admit to intensive care if APACHE II >8, organ failure develops, or clinical deterioration occurs 1, 3
No laboratory test, including enzyme levels, consistently predicts severity—clinical assessment and scoring systems are more reliable 1

Ultrasound identifies gallstones in most biliary cases 1
Combined bilirubin elevation ≥2× ULN with elevated enzymes strongly suggests biliary obstruction 3
Measure serum triglycerides and calcium if gallstones absent and no significant alcohol history 1
Triglyceride levels >1000 mg/dL (>11.3 mmol/L) indicate hypertriglyceridemia as the cause 1

Serial clinical examinations are the most important follow-up tool 1, 3
Monitor for resolution of abdominal pain, tolerance of oral intake, and absence of systemic inflammatory signs 1
Assess for complications including persisting organ failure or sepsis, particularly 6-10 days after admission 1
Perform CT for patients with persisting organ failure, signs of sepsis, or deterioration 6-10 days after admission 1

Use enzyme levels to determine timing of oral feeding or discharge—use clinical parameters instead 1
Trend lipase/amylase serially for monitoring disease progression—they have no utility for this purpose 1
Delay CT imaging in deteriorating patients while waiting for enzyme changes 1
Assume normal or mildly elevated enzymes exclude severe disease 1

In traumatic pancreatic injury specifically, measuring enzymes every 6 hours starting 3-6 hours post-injury may support clinical evaluation, with rising levels indicating need for CT imaging 4, 1
Persistently elevated amylase after 10 days warrants monitoring for pseudocyst formation 1